Neuroscience News and Research

RSS

Results from HSPPC-96 Phase 2 study against recurrent gliobastoma presented at ASCO 2011

In data presented at The American Society of Clinical Oncology (ASCO) Annual Meeting, cancer researchers found that the brain tumor vaccine HSPPC-96 for treating recurrent gliobastoma (GBM) has a favorable safety profile and extends survival by two to three times more than the current median survival rate.

4 Jun 2011

Genentech, Astellas announce results of Tarceva Phase III study against advanced NSCLC

Genentech, a member of the Roche Group and Astellas Pharma US, Inc., today announced results of EURTAC, the first Phase III study with Tarceva in Western patients with a genetically distinct type of advanced non-small cell lung cancer (NSCLC).

4 Jun 2011

Patch-clamp recording reveals subtle differences between two neurotransmitter-gated ion channels

Using a high-resolution single-molecule study technique, University of Illinois researchers have seen the very subtle differences between two branches of an important family of neurotransmitter-gated ion channels.

3 Jun 2011

Teva completes patient enrollment in COPAXONE Phase III trial for treatment of multiple sclerosis

Teva Pharmaceutical Industries Ltd. today announced completion of patient enrollment for the GALA (Glatiramer Acetate Low-frequency Administration) trial.

3 Jun 2011

Scientists uncover new therapeutic target that could prevent stress-related cell death

Scientists from the Florida campus of The Scripps Research Institute have uncovered a potentially important new therapeutic target that could prevent stress-related cell death, a characteristic of neurodegenerative diseases such as Parkinson's, as well as heart attack and stroke.

3 Jun 2011

Scientists discover new compound that inhibits bitterness

Although bitterness can sometimes be desirable - such as in the taste of coffee or chocolate - more often bitter taste causes rejection that can interfere with food selection, nutrition and therapeutic compliance. This is especially true for children. Now, scientists from the Monell Center and Integral Molecular describe the discovery of a compound that inhibits bitterness by acting directly on a subset of bitter taste receptors.

3 Jun 2011

'Provision of choice' strategy helps improve vegetable consumption in children

A gesture as simple as allowing children to freely choose the vegetables they want to eat helps to increase the consumption of these foods in children, as University of Granada has found.

3 Jun 2011

Scientists locate brain region responsible for scene-facilitation effect

Scientists at the University of Southern California have pinned down the region of the brain responsible for a key survival trait: our ability to comprehend a scene-even one never previously encountered-in a fraction of a second.

2 Jun 2011

Preliminary results from Eisai's lenvatinib Phase II trial in thyroid cancer to be presented at ASCO 2011

Preliminary results of a Phase II single-arm study to be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting showed that Eisai's lenvatinib demonstrated an Objective Response Rate of 59% (34/58, 95% CI: 45-71), based on an updated investigator assessment, in patients with advanced radioiodine (RAI)-refractory differentiated thyroid cancer.

1 Jun 2011

Suberoylanilide hydroxamic acid holds promise against familial frontotemporal dementia

A drug already approved for people with cancer shows early potential as a therapy for a common form of dementia, UT Southwestern Medical Center researchers report.

1 Jun 2011

Heptares, AstraZeneca partner to discover and develop new GPCR drug targets

AstraZeneca and Heptares Therapeutics today announced they have entered a four-year collaboration focused on the potential discovery and development of new medicines targeting G-protein coupled receptors.

31 May 2011

Stress does not appear to increase risk of developing multiple sclerosis

Contrary to earlier reports, a new study finds that stress does not appear to increase a person's risk of developing multiple sclerosis. The research is published in the May 31, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.

31 May 2011

Study examines brain and behavior relationships in response to morally laden scenarios

People's moral responses to similar situations change as they age, according to a new study at the University of Chicago that combined brain scanning, eye-tracking and behavioral measures to understand how the brain responds to morally laden scenarios.

30 May 2011

Multiple exposures to anesthesia may increase risk of ADHD, learning disabilities in young children

Infants and very young children who are exposed to anesthesia may experience higher rates of learning disabilities and cognitive difficulties than children who are not exposed to anesthesia, according to research and emerging data presented during the SmartTots: Pediatric Anesthesia Neurotoxicity panel at the International Anesthesia Research Society annual meeting in Vancouver, B.C.

30 May 2011

NIH awards $2.4 million, five-year grant for research on dementia and delirium

Adults with dementia and delirium may soon have a way to combat their delirium, thanks to a $2.4 million, five-year grant from the National Institutes of Health.

27 May 2011

Patients with body dysmorphic disorder have less brain activity in visual processing

People suffering from body dysmorphic disorder, or BDD - a severe mental illness characterized by debilitating misperceptions that one appears disfigured and ugly - process visual information abnormally, even when looking at inanimate objects, according to a new UCLA study.

27 May 2011

Difficulty to learn maths linked to neurocognitive disorder

Students who struggle to learn mathematics may have a neurocognitive disorder that inhibits the acquisition of basic numerical and arithmetic concepts, according to a new paper by University of Minnesota and British researchers. Called developmental dyscalculia, the disorder affects roughly the same number of people as dyslexia but has received much less attention (and research funding).

27 May 2011

Albert Einstein College of Medicine to help shed light on causes and treatments of type 2 diabetes

Fifty years ago, adult-onset diabetes was relatively rare, affecting less than one percent of the adult population in the United States. Today, more than 25 million Americans over the age of 20 battle the disease - an alarming 11 percent of the population.

27 May 2011

CAS, University of Pennsylvania collaborate to develop joint Center of Excellence in Brain Mapping

In a ceremony today, the University of Pennsylvania announced a collaboration agreement with the Chinese Academy of Sciences to develop a joint Center of Excellence in Brain Mapping for the purpose of collaborative research and education in neuroimaging.

27 May 2011

Neurologix presents NLX-P101 Phase 2 trial in Parkinson's disease at 10th INS World Congress

Neurologix, Inc. announced the presentation today of efficacy results through one year of follow-up in patients treated as part of the Company's successful Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease.

27 May 2011

Neuroscience News and Research

Results from HSPPC-96 Phase 2 study against recurrent gliobastoma presented at ASCO 2011

Genentech, Astellas announce results of Tarceva Phase III study against advanced NSCLC

Patch-clamp recording reveals subtle differences between two neurotransmitter-gated ion channels

Teva completes patient enrollment in COPAXONE Phase III trial for treatment of multiple sclerosis

Scientists uncover new therapeutic target that could prevent stress-related cell death

Scientists discover new compound that inhibits bitterness

'Provision of choice' strategy helps improve vegetable consumption in children

Scientists locate brain region responsible for scene-facilitation effect

Preliminary results from Eisai's lenvatinib Phase II trial in thyroid cancer to be presented at ASCO 2011

Suberoylanilide hydroxamic acid holds promise against familial frontotemporal dementia

Heptares, AstraZeneca partner to discover and develop new GPCR drug targets

Stress does not appear to increase risk of developing multiple sclerosis

Study examines brain and behavior relationships in response to morally laden scenarios

Multiple exposures to anesthesia may increase risk of ADHD, learning disabilities in young children

NIH awards $2.4 million, five-year grant for research on dementia and delirium

Patients with body dysmorphic disorder have less brain activity in visual processing

Difficulty to learn maths linked to neurocognitive disorder

Albert Einstein College of Medicine to help shed light on causes and treatments of type 2 diabetes

CAS, University of Pennsylvania collaborate to develop joint Center of Excellence in Brain Mapping

Neurologix presents NLX-P101 Phase 2 trial in Parkinson's disease at 10th INS World Congress

Event guide: 8th Neuroimmunology Drug Development Summit 2026 eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News